The Xeltis synthetic polymer restorative pulmonary valve is implanted surgically and acts as a scaffold for the patient's own cells to proliferate. The valve and conduit then bioresorbs over time, leaving behind a new valve made from the patient's own cells. The hope is this will reduce or eliminate the need for numerous repeat surgeries as a pediatric patient grows.
Feature | Heart Valve Technology
Xeltis Begins Pivotal Trial for Pulmonary Valve That Grows With the Patient

July 8, 2021 – Xeltis announced it started the first pivotal trial for a synthetic polymer restorative pulmonary valve ...

Home July 08, 2021
Home
The Robocath R-One cath lab robotic platform being used in Rouen, France, to guide a cardiac Cath procedure. The system gained European approval in 2019. Robocath is now partnering with Philips France and Rennes University Hospital to develop the robotic system to treat strokes.
News | Stroke
Robocath, Philips and Rennes University Hospital Codevelop Robotic Stroke Intervention System

July 7, 2021 – Robocath, a company that designs, develops and commercializes cath lab robotic solutions to treat ...

Home July 07, 2021
Home
Ultra-fast, less than one-minute scan time, cardiac MRI enables accurate assessment of heart anatomy and function, improves patient comfort, increases access to care, and reduces costs
News | Magnetic Resonance Imaging (MRI)
Philips and the Spanish National Center for Cardiovascular Research Collaborate on New Ultra-fast Cardiac MRI Protocol

July 2, 2021 — Philips has participated in an important research project to develop a magnetic resonance (MR) imaging ...

Home July 02, 2021
Home
Videos | Artificial Intelligence
VIDEO: Artificial Intelligence Identifies High-Risk COVID Patients From Cardiac Ultrasounds

Federico Asch, M.D., FASE, director of cardiovascular core labs, cardiovascular imaging, MedStar Health Research ...

Home July 01, 2021
Home
The FDA has cleared Angel Medical Systems' second-generation AngelMed Guardian device. The implantable cardiac device detects and warns patients if they are having an acute coronary syndrome (ACS) event, including silent heart attacks. The new, second-generation device is enhanced with ease-of-use adaptations and an updated, long life battery that could potentially double the life of the implanted device
News | Cardiac Diagnostics
FDA Approves AngelMed Enhanced Real-Time Cardiac Monitor for Acute Coronary Syndrome (ACS) Events

July 1, 2021 — The U.S. Food and Drug Administration (FDA) has cleared the Angel Medical Systems Inc. second-generation ...

Home July 01, 2021
Home
Abbott says the Xience fluoropolymer coating interacts with blood proteins in a manner that reduces thrombus formation. This feature makes the stent safer to use for shorter duration DAPT.
News | Stents
FDA Clears Xience Stent for One Month DAPT in High Risk Bleeding Patients

June 30, 2021 — Abbott announced its Xience family of drug-eluting coronary stents received U.S. Food and Drug ...

Home June 30, 2021
Home
Echocardiography Related COVID-19 Research Presented at ASE 2021
News | Cardiovascular Ultrasound
Echocardiography Related COVID-19 Research Presented at ASE 2021

June 29, 2021 – A new original science category being featured at the American Society of Echocardiography (ASE) 2021 ...

Home June 29, 2021
Home
3 Studies Show How Echocardiography is a Key Tool in Women's Health. Getty Images
News | Womens Cardiovascular Health
3 Studies Show How Echocardiography is a Key Tool in Women's Health

June 29, 2021 – Three research studies presented at the American Society of Echocardiography (ASE) 2021 virtual meeting ...

Home June 29, 2021
Home
Images from the ASE presentation. Left, UEA echo showing focal narrowing of the SCPC anastomosis and the same view on invasive angiography. Right, UAE echo showing complete occlusion of pulmonary artery and angiography showing the same view.
News | Congenital Heart
Ultrasound Contrast Agents Greatly Aids in Complex Congenital Heart Imaging

June 29, 2021 – Echocardiography with ultrasound enhancing agents (UEAs) has proven to be a valuable imaging procedure ...

Home June 29, 2021
Home
New cardiac ultrasound technologies featured at the American Society of Echocardiography 2021 Virtual Meeting include intracardiac ultrasound (ICE) imaging from Biosense Webster (left), and cloud-based, vendor-neutral strain imaging from Epsilon Imaging (right).
News | ASE
New Technologies Featured at the American Society of Echocardiography 2021 Virtual Meeting

June 29, 2021 – The virtual exhibit hall at American Society of Echocardiography (ASE) 2021 Scientific Sessions Virtual ...

Home June 29, 2021
Home
The balloon inflation to deploy an Edwards Lifesciences Sapien 3 TAVR valve in a failed surgical tricuspid valve. This valve-in-valve (VIV) procedures was performed at Beaumont in a 34-year-old female patient who was determined to be too high of a surgical risk for SAVR.
News | Structural Heart
Beaumont Performs Rare Tricuspid Transcatheter Valve-in-valve Procedure

June 29, 2021 – Cardiologists at Beaumont Health successfully replaced a 34-year-old woman’s tricuspid valve in a rare ...

Home June 29, 2021
Home
ScImage went live in March at Peak Surgery Center of Avondale, Arizona, and was developed in cooperation with the providers from multispecialty cardiovascular group Peak Heart & Vascular, which has locations in Avondale, Surprise, Ariz., and Flagstaff, Ariz. ScImage’s PICOM365 Cloud provides image review, storage and advanced structured reporting to manage the complex, measurement-centric cardiac catheterization procedures performed in the facilities.
News | Cardiovascular Information Systems (CVIS)
Outpatient Cath Lab Adopts PICOM365 Cloud With Hemodynamics 

June 29, 2021 - ScImage Inc.has partnered with National Cardiovascular Management (NCM), a national consulting and ...

Home June 29, 2021
Home
CentraCare completed the first structural heart procedure in the world guided by a new 4-D hologram technology developed by EchoPixel. The augmented reality technology aims to reduce reduce procedure time, improve accuracy of the procedure, and reduce risk of complications.
Feature | Virtual and Augmented Reality
First 4D Hologram Guided Structural Heart Procedure Performed for LAA Occlusion

June 28, 2021 — CentraCare, one of the largest health systems in Minnesota, successfully completed the first structural ...

Home June 28, 2021
Home
Circle Cardiovascular Imaging Partners With DiA Imaging Analysis to Deliver AI-Based Cardiovascular Imaging Solutions
News | Artificial Intelligence
Circle Cardiovascular Imaging Partners With DiA Imaging Analysis to Deliver AI-Based Cardiovascular Imaging Solutions

June 28, 2021 — Circle Cardiovascular Imaging Inc. and DiA Imaging Analysis Ltd. entered into a multi-year partnership ...

Home June 28, 2021
Home
Researchers analyzing surveillance data on 518 children and adolescents with MIS-C who were admitted to U.S. hospitals in 2020 fopiund those treated with intravenous immune globulin (IVIG) plus glucocorticoids had a lower risk of new or persistent cardiovascular dysfunction than IVIG alone. Left photo Getty Images, right photo Nemours Children’s Health System.
News | Coronavirus (COVID-19)
Study Provides MIS-C Treatment Guidance To Avoid Cardiovascular Dysfunction

June 28, 2021 - A recent analysis found that children and adolescents with multisystem inflammatory syndrome in children ...

Home June 28, 2021
Home
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now